Cargando…

Employing the therapeutic operating characteristic (TOC) graph for individualised dose prescription

BACKGROUND: In current practice, patients scheduled for radiotherapy are treated according to ‘rigid’ protocols with predefined dose prescriptions that do not consider risk-taking preferences of individuals. The therapeutic operating characteristic (TOC) graph is applied as a decision-aid to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Aswin L, Huizenga, Henk, Kaanders, Johannes HAM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606307/
https://www.ncbi.nlm.nih.gov/pubmed/23497640
http://dx.doi.org/10.1186/1748-717X-8-55
_version_ 1782263982398111744
author Hoffmann, Aswin L
Huizenga, Henk
Kaanders, Johannes HAM
author_facet Hoffmann, Aswin L
Huizenga, Henk
Kaanders, Johannes HAM
author_sort Hoffmann, Aswin L
collection PubMed
description BACKGROUND: In current practice, patients scheduled for radiotherapy are treated according to ‘rigid’ protocols with predefined dose prescriptions that do not consider risk-taking preferences of individuals. The therapeutic operating characteristic (TOC) graph is applied as a decision-aid to assess the trade-off between treatment benefit and morbidity to facilitate dose prescription customisation. METHODS: Historical dose-response data from prostate cancer patient cohorts treated with 3D-conformal radiotherapy is used to construct TOC graphs. Next, intensity-modulated (IMRT) plans are generated by optimisation based on dosimetric criteria and dose-response relationships. TOC graphs are constructed for dose-scaling of the optimised IMRT plan and individualised dose prescription. The area under the TOC curve (AUC) is estimated to measure the therapeutic power of these plans. RESULTS: On a continuous scale, the TOC graph directly visualises treatment benefit and morbidity risk of physicians’ or patients’ choices for dose (de-)escalation. The trade-off between these probabilities facilitates the selection of an individualised dose prescription. TOC graphs show broader therapeutic window and higher AUCs with increasing target dose heterogeneity. CONCLUSIONS: The TOC graph gives patients and physicians access to a decision-aid and read-out of the trade-off between treatment benefit and morbidity risks for individualised dose prescription customisation over a continuous range of dose levels.
format Online
Article
Text
id pubmed-3606307
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36063072013-03-27 Employing the therapeutic operating characteristic (TOC) graph for individualised dose prescription Hoffmann, Aswin L Huizenga, Henk Kaanders, Johannes HAM Radiat Oncol Research BACKGROUND: In current practice, patients scheduled for radiotherapy are treated according to ‘rigid’ protocols with predefined dose prescriptions that do not consider risk-taking preferences of individuals. The therapeutic operating characteristic (TOC) graph is applied as a decision-aid to assess the trade-off between treatment benefit and morbidity to facilitate dose prescription customisation. METHODS: Historical dose-response data from prostate cancer patient cohorts treated with 3D-conformal radiotherapy is used to construct TOC graphs. Next, intensity-modulated (IMRT) plans are generated by optimisation based on dosimetric criteria and dose-response relationships. TOC graphs are constructed for dose-scaling of the optimised IMRT plan and individualised dose prescription. The area under the TOC curve (AUC) is estimated to measure the therapeutic power of these plans. RESULTS: On a continuous scale, the TOC graph directly visualises treatment benefit and morbidity risk of physicians’ or patients’ choices for dose (de-)escalation. The trade-off between these probabilities facilitates the selection of an individualised dose prescription. TOC graphs show broader therapeutic window and higher AUCs with increasing target dose heterogeneity. CONCLUSIONS: The TOC graph gives patients and physicians access to a decision-aid and read-out of the trade-off between treatment benefit and morbidity risks for individualised dose prescription customisation over a continuous range of dose levels. BioMed Central 2013-03-07 /pmc/articles/PMC3606307/ /pubmed/23497640 http://dx.doi.org/10.1186/1748-717X-8-55 Text en Copyright ©2013 Hoffmann et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Hoffmann, Aswin L
Huizenga, Henk
Kaanders, Johannes HAM
Employing the therapeutic operating characteristic (TOC) graph for individualised dose prescription
title Employing the therapeutic operating characteristic (TOC) graph for individualised dose prescription
title_full Employing the therapeutic operating characteristic (TOC) graph for individualised dose prescription
title_fullStr Employing the therapeutic operating characteristic (TOC) graph for individualised dose prescription
title_full_unstemmed Employing the therapeutic operating characteristic (TOC) graph for individualised dose prescription
title_short Employing the therapeutic operating characteristic (TOC) graph for individualised dose prescription
title_sort employing the therapeutic operating characteristic (toc) graph for individualised dose prescription
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606307/
https://www.ncbi.nlm.nih.gov/pubmed/23497640
http://dx.doi.org/10.1186/1748-717X-8-55
work_keys_str_mv AT hoffmannaswinl employingthetherapeuticoperatingcharacteristictocgraphforindividualiseddoseprescription
AT huizengahenk employingthetherapeuticoperatingcharacteristictocgraphforindividualiseddoseprescription
AT kaandersjohannesham employingthetherapeuticoperatingcharacteristictocgraphforindividualiseddoseprescription